首页> 外文期刊>Cell Reports >Early-Onset Hypertrophic Cardiomyopathy Mutations Significantly Increase the Velocity, Force, and Actin-Activated ATPase Activity of Human @b-Cardiac Myosin
【24h】

Early-Onset Hypertrophic Cardiomyopathy Mutations Significantly Increase the Velocity, Force, and Actin-Activated ATPase Activity of Human @b-Cardiac Myosin

机译:早发型肥厚性心肌病突变显着增加人@b心肌肌球蛋白的速度,力和肌动蛋白激活的ATPase活性。

获取原文
           

摘要

Hypertrophic cardiomyopathy (HCM) is a heritable cardiovascular disorder that affects 1 in 500 people. A significant percentage of HCM is attributed to mutations in @b-cardiac myosin, the motor protein that powers ventricular contraction. This study reports how two early-onset HCM mutations, D239N and H251N, affect the molecular biomechanics of human @b-cardiac myosin. We observed significant increases (20%-90%) in actin gliding velocity, intrinsic force, and ATPase activity in comparison to wild-type myosin. Moreover, for H251N, we found significantly lower binding affinity between the S1 and S2 domains of myosin, suggesting that this mutation may further increase hyper-contractility by releasing active motors. Unlike previous HCM mutations studied at the molecular level using human @b-cardiac myosin, early-onset HCM mutations lead to significantly larger changes in the fundamental biomechanical parameters and show clear hyper-contractility.
机译:肥厚型心肌病(HCM)是一种遗传性心血管疾病,每500人中有1人受到影响。 HCM的很大一部分归因于@ b-心肌肌球蛋白的突变,后者是促进心室收缩的运动蛋白。这项研究报告了两个早发性HCM突变D239N和H251N如何影响人b心肌肌球蛋白的分子生物力学。与野生型肌球蛋白相比,我们观察到肌动蛋白滑动速度,内在力和ATPase活性显着增加(20%-90%)。此外,对于H251N,我们发现肌球蛋白的S1和S2结构域之间的结合亲和力明显较低,这表明该突变可通过释放主动马达进一步增加超收缩能力。与以前使用人@ b-心肌肌球蛋白在分子水平上研究的HCM突变不同,早期发作的HCM突变导致基本生物力学参数的变化明显更大,并且显示出明显的过度收缩。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号